Research ArticleHuman Studies
Rhenium-186-Labeled Chimeric Antibody NR-LU-13: Pharmacokinetics, Biodistribution and Immunogenicity Relative to Murine Analog NR-LU-10
Paul L. Weiden, Hazel B. Breitz, Christine A. Seiler, Michael J. Bjorn, Barbara A. Ratliff, Robert Mallett, Paul L. Beaumier, Janet W. Appelbaum, Alan R. Fritzberg and Darrell Salk
Journal of Nuclear Medicine December 1993, 34 (12) 2111-2119;
Paul L. Weiden
Hazel B. Breitz
Christine A. Seiler
Michael J. Bjorn
Barbara A. Ratliff
Robert Mallett
Paul L. Beaumier
Janet W. Appelbaum
Alan R. Fritzberg
This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Rhenium-186-Labeled Chimeric Antibody NR-LU-13: Pharmacokinetics, Biodistribution and Immunogenicity Relative to Murine Analog NR-LU-10
Paul L. Weiden, Hazel B. Breitz, Christine A. Seiler, Michael J. Bjorn, Barbara A. Ratliff, Robert Mallett, Paul L. Beaumier, Janet W. Appelbaum, Alan R. Fritzberg, Darrell Salk
Journal of Nuclear Medicine Dec 1993, 34 (12) 2111-2119;
Rhenium-186-Labeled Chimeric Antibody NR-LU-13: Pharmacokinetics, Biodistribution and Immunogenicity Relative to Murine Analog NR-LU-10
Paul L. Weiden, Hazel B. Breitz, Christine A. Seiler, Michael J. Bjorn, Barbara A. Ratliff, Robert Mallett, Paul L. Beaumier, Janet W. Appelbaum, Alan R. Fritzberg, Darrell Salk
Journal of Nuclear Medicine Dec 1993, 34 (12) 2111-2119;
Jump to section
Related Articles
- No related articles found.